1 asset in Atypical Carcinoid Tumor
Therapeutic assets addressing Atypical Carcinoid Tumor, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nivolumab Atypical Carcinoid Tumor | M.D. Anderson Cancer Center | P2 | CCC (53) |